ROCKETing-Forward-The-Future-of-Atopic-Dermatitis-Treatment-Targeting-the-OX40-Signalling-Pathway-3

ROCKETing-Forward-The-Future-of-Atopic-Dermatitis-Treatment-Targeting-the-OX40-Signalling-Pathway-3 by Amgen.